World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 9 January 2017
Main ID:  NCT02794987
Date of registration: 01/05/2016
Prospective Registration: No
Primary sponsor: Instituto Ecuatoriano de Enfermedades Digestivas
Public title: Cholangioscopic Classification of Bile Duct Lesions
Scientific title: Proposal of a Macroscopic Classification for Tissular Lesions of the Bile Duct Detected During Per Oral Cholangioscopy (POCS)
Date of first enrolment: December 2015
Target sample size: 130
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02794987
Study type:  Observational
Study design:  Observational Model: Case-Crossover, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Ecuador
Contacts
Name:     Carlos A Robles-Medranda, MD
Address: 
Telephone:
Email:
Affiliation:  Ecuadorian Institute of Digestive Diseases
Key inclusion & exclusion criteria

Inclusion Criteria:

- Above 18 years old patients

- Who agree to participate in the study

- Patients with tissular biliary lesions detected by POCS

Exclusion Criteria:

- Tissular lesions with no histology confirmation (either biopsy or surgical resection
in case of malignancy suspicion) or 6 months follow-up by POCS (in case of benign
suspicion)

- Severe uncontrolled coagulopathy

- Esophageal, gastric or duodenal stenosing tumors with no possibility of scope passage

- Prior history of esophageal, gastric or surgery with no possibility of scope passage

- Contrast allergy

- Pregnancy and lactation



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Bile Duct Lesions
Intervention(s)
Device: SpyGlass® choledoscopy
Primary Outcome(s)
The accuracy, sensitivity, specificity, positive and negative predictive value of the macroscopic classification will be measure in order to perform a prospective validation of the classification. [Time Frame: 12 month]
Evaluation of vascular and surface features of benign and malignant lesions detected by POCS images, that could be used to perform a macroscopic classification of bile duct tissular lesions [Time Frame: 24 month]
Secondary Outcome(s)
Secondary ID(s)
MAY-1-2016
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history